Genocea Biosciences Beheer
Beheer criteriumcontroles 2/4
We currently do not have sufficient information about the CEO.
Belangrijke informatie
Chip Clark
Algemeen directeur
US$3.8m
Totale compensatie
Percentage CEO-salaris | 15.2% |
Dienstverband CEO | 12.3yrs |
Eigendom CEO | n/a |
Management gemiddelde ambtstermijn | 7.3yrs |
Gemiddelde ambtstermijn bestuur | 8.7yrs |
Recente managementupdates
Recent updates
Here's Why Shareholders May Want To Be Cautious With Increasing Genocea Biosciences, Inc.'s (NASDAQ:GNCA) CEO Pay Packet
Jun 17What Type Of Returns Would Genocea Biosciences'(NASDAQ:GNCA) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?
Feb 18How Much Of Genocea Biosciences, Inc. (NASDAQ:GNCA) Do Institutions Own?
Jan 14Analyse CEO-vergoeding
Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
---|---|---|---|
Mar 31 2022 | n/a | n/a | -US$37m |
Dec 31 2021 | US$4m | US$571k | -US$33m |
Sep 30 2021 | n/a | n/a | -US$35m |
Jun 30 2021 | n/a | n/a | -US$36m |
Mar 31 2021 | n/a | n/a | -US$43m |
Dec 31 2020 | US$1m | US$551k | -US$44m |
Sep 30 2020 | n/a | n/a | -US$38m |
Jun 30 2020 | n/a | n/a | -US$41m |
Mar 31 2020 | n/a | n/a | -US$36m |
Dec 31 2019 | US$1m | US$533k | -US$39m |
Sep 30 2019 | n/a | n/a | -US$29m |
Jun 30 2019 | n/a | n/a | -US$30m |
Mar 31 2019 | n/a | n/a | -US$27m |
Dec 31 2018 | US$1m | US$515k | -US$28m |
Sep 30 2018 | n/a | n/a | -US$39m |
Jun 30 2018 | n/a | n/a | -US$48m |
Mar 31 2018 | n/a | n/a | -US$59m |
Dec 31 2017 | US$2m | US$493k | -US$57m |
Sep 30 2017 | n/a | n/a | -US$62m |
Jun 30 2017 | n/a | n/a | -US$58m |
Mar 31 2017 | n/a | n/a | -US$54m |
Dec 31 2016 | US$1m | US$455k | -US$50m |
Compensatie versus markt: Chip's total compensation ($USD3.75M) is above average for companies of similar size in the US market ($USD740.57K).
Compensatie versus inkomsten: Chip's compensation has increased whilst the company is unprofitable.
CEO
Chip Clark (53 yo)
12.3yrs
Tenure
US$3,750,857
Compensatie
Mr. William D. Clark, M.B.A., also known as Chip, has been an Independent Director at iBio, Inc. since August 26, 2021 and serves as its Chairman since November 2022. He has been the Director, Chief Execut...
Leiderschapsteam
Naam | Positie | Tenure | Compensatie | Eigendom |
---|---|---|---|---|
President | 12.3yrs | US$3.75m | geen gegevens | |
Chief Scientific Officer | 7.3yrs | US$1.27m | geen gegevens | |
CFO & Secretary | 4.2yrs | geen gegevens | geen gegevens |
7.3yrs
Gemiddelde duur
50yo
Gemiddelde leeftijd
Ervaren management: GNCA.Q's management team is seasoned and experienced (7.3 years average tenure).
Bestuursleden
Naam | Positie | Tenure | Compensatie | Eigendom |
---|---|---|---|---|
President | 12.3yrs | US$3.75m | geen gegevens | |
Independent Chairman of the Board | 8.7yrs | US$120.98k | geen gegevens | |
Independent Director | 8.3yrs | US$78.48k | geen gegevens | |
Independent Director | 10.2yrs | US$75.88k | geen gegevens | |
Independent Chairman of Scientific Advisory Board & Director | 16.3yrs | US$66.98k | geen gegevens | |
Member of Scientific Advisory Board | no data | geen gegevens | geen gegevens | |
Independent Director | 1.7yrs | US$61.50k | geen gegevens | |
Member of Scientific Advisory Board | no data | geen gegevens | geen gegevens | |
Member of Scientific Advisory Board | no data | geen gegevens | geen gegevens | |
Member of Scientific Advisory Board | no data | geen gegevens | geen gegevens | |
Independent Director | 1.2yrs | geen gegevens | geen gegevens |
8.7yrs
Gemiddelde duur
53.5yo
Gemiddelde leeftijd
Ervaren bestuur: GNCA.Q's board of directors are considered experienced (8.7 years average tenure).